Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC
about
Immunohistochemical expression of insulin-like growth factor binding protein-3 in invasive breast cancers and ductal carcinoma in situ: implications for clinicopathology and patient outcome.Detection of hepatocyte growth factor/scatter factor receptor (c-Met) in axillary drainage after operations for breast cancer using reverse transcriptase-polymerase chain reactionp14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2Expression of oestrogen receptor beta (ERbeta1) protein in human breast cancer biopsiesImprovement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues.Prolactinoma ErbB receptor expression and targeted therapy for aggressive tumors.HER2-positive circulating tumor cells in breast cancerCOX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatmentOverexpression of Rsf-1 correlates with pathological type, p53 status and survival in primary breast cancerGenotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas.Molecular subtyping of DCIS: heterogeneity of breast cancer reflected in pre-invasive disease.Breast cancer hormone receptor assay results of core needle biopsy and modified radical mastectomy specimens from the same patients.XRCC3 and RAD51 expression are associated with clinical factors in breast cancer.The effect of freezing on the immunoprofile of breast carcinoma cells.Statistical association of basal cell keratins with metastasis-inducing proteins in a prognostically unfavorable group of sporadic breast cancers.G-protein Coupled Estrogen Receptor 1 Expression in Primary Breast Cancers and Its Correlation with Clinicopathological Variables.Cellular and molecular regulation of the primate endometrium: a perspectiveSelective Targeting to Glioma with Nucleic Acid AptamersSimultaneous evaluation of maspin and CXCR4 in patients with breast cancer.DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis.Correlation of Hormone Receptor Expression with Histologic Parameters in Benign and Malignant Breast Tumors.Enhanced RAD21 cohesin expression confers poor prognosis in BRCA2 and BRCAX, but not BRCA1 familial breast cancers.The impact of PTEN tumor suppressor gene on acquiring resistance to tamoxifen treatment in breast cancer patientsUncovering the genomic heterogeneity of multifocal breast cancer.Oestrogen receptor beta and neoadjuvant therapy with tamoxifen: prediction of response and effects of treatment.Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index.Evaluation of the current knowledge limitations in breast cancer research: a gap analysisPhosphorylated-p38 mitogen-activated protein kinase expression is associated with clinical factors in invasive breast cancer.Study of hormone receptors and epidermal growth factor expression in invasive breast cancers in a cohort of Western India.Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1.Androgen-related expression of G-proteins in ovarian cancer.Molecular characteristics of screen-detected vs symptomatic breast cancers and their impact on survival.The use of mouse models of breast cancer and quantitative image analysis to evaluate hormone receptor antigenicity after microwave-assisted formalin fixationBreast cancer metastasis: demonstration that FOXP3 regulates CXCR4 expression and the response to CXCL12.The difference in miR-21 expression levels between invasive and non-invasive breast cancers emphasizes its role in breast cancer invasion.Operation with less adjuvant therapy for elderly breast cancer.Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients.Oestrogen and progesterone receptors in breast cancer: past, present and future.The Japanese Breast Cancer Society clinical practice guidelines for pathological diagnosis of breast cancer, 2015 edition.The role of androgen receptor expression in the curative treatment of prostate cancer with radiotherapy: a pilot study
P2860
Q24796824-BE583D67-CA82-491B-B953-3F9B3EF62736Q24803522-1A19E589-BB1E-413F-AFC1-4E2C0A0E4B30Q24806368-10BACCAD-4927-4FF2-8E17-571F42D0486FQ31040434-44675E82-4C4F-4989-9E83-F6525013409FQ33501853-21D973E1-F386-491D-8C70-62BB71C6AEF9Q33680681-997A6F61-7B78-419B-BFB8-31EE935ABFA4Q33802925-8595C21D-232C-448A-8536-7C51CBE00E4CQ33877411-9D7A5448-F330-488F-8045-7077AC32D33DQ34371225-53154A91-FFA0-45A7-B767-1964677CE962Q34475135-20986D20-7D1E-4510-ADD8-1930EC5D5878Q34577467-D40B7FEB-DE63-4448-8BCD-4D31EEC34D68Q34640721-FAEE5792-1892-4965-AB15-8871BEF64457Q34973239-32396227-AE2D-4451-987E-39FD9F6579C1Q35053377-5D275D6A-6F21-4402-9D11-4A6B4DFC7127Q35168065-2BEE4B6C-2266-4C47-A71B-767168CB2498Q35435464-B46BE5A2-E62E-4E7B-968E-B7E7670DAFF6Q35598634-94519D06-5E5F-4ECD-8F37-D77149360DA8Q35740074-EC2B2ADD-0F60-4297-AC62-F565A4920C65Q35770530-157ADD9C-5448-4743-A7DE-21E4B733679BQ35941085-1976F6D0-A517-4905-A299-FE32B1D637DBQ35964928-C92E0136-37D7-47D3-BE94-0656A8538D83Q36245645-AA7F8B90-18F6-48BB-B54B-B8E75A1441DEQ36312142-643EE043-DD82-49E6-9D2A-A02EF1A5CB48Q36404728-43E160CE-4F6D-4130-A144-A6ED73345F75Q36614596-90ECC4AB-CB04-4DE2-8C97-BD5C3553D408Q36624255-17ED5435-4F53-403A-9CA2-B64EFC1239CEQ36678664-FB530811-02F6-49F4-BEB7-42D8581EE169Q37056598-EB3443DD-D6B8-4A20-AE9A-756A707D647DQ37199409-75C6C66D-B1CF-4CD1-9CA5-94F43207B0DFQ37269294-967895FE-52AC-49F9-95A8-AE892A103888Q37287519-FFA1BDE0-12E3-4250-8A79-5179A79D1987Q37401549-272271FB-D142-470E-9F3B-AE27F5827A88Q37733734-8A29F50D-ED59-4553-AD2C-48A06859D258Q38990809-A36E36AC-12F3-4513-AB92-E6973EB72115Q39258051-1135D377-4248-46BC-9FEE-43DBA3837528Q39450470-2CAF3496-C2BE-434F-B7BB-FC1382569C76Q39902528-3AC5F7E7-0AF6-40AA-87DD-178E9ECE01CDQ40718234-8D086AF0-044E-4128-AB8D-B3D55D66E72FQ40777892-CE386381-6EEF-42C7-963B-856728841883Q41963995-5D6815A7-6EF6-4081-B012-299726F649E4
P2860
Immunohistochemical detection of steroid receptors in breast cancer: a working protocol. UK Receptor Group, UK NEQAS, The Scottish Breast Cancer Pathology Group, and The Receptor and Biomarker Study Group of the EORTC
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Immunohistochemical detection ...... arker Study Group of the EORTC
@ast
Immunohistochemical detection ...... arker Study Group of the EORTC
@en
type
label
Immunohistochemical detection ...... arker Study Group of the EORTC
@ast
Immunohistochemical detection ...... arker Study Group of the EORTC
@en
prefLabel
Immunohistochemical detection ...... arker Study Group of the EORTC
@ast
Immunohistochemical detection ...... arker Study Group of the EORTC
@en
P2093
P356
P1476
Immunohistochemical detection ...... arker Study Group of the EORTC
@en
P2093
Anderson L
Anderson T
P304
P356
10.1136/JCP.53.8.634
P407
P577
2000-08-01T00:00:00Z